KORU Medical Systems, Inc.
KORU Medical Systems, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 8 | 9 | 9 | 8 | 8 | 9 | 10 | 9 | 10 | 11 | 11 | 11 | |||||
Accounts Receivable Net Current | - | 6 | 6 | 5 | 5 | 6 | 6 | 5 | 6 | 4 | 4 | 4 | |||||
Inventory Net | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 3 | 3 | 3 | 5 | |||||
Other Receivables | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 1 | |||||
Prepaid Expense Current | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | |||||
Assets Current | 20 | 21 | 20 | 19 | 18 | 19 | 19 | 19 | 19 | 19 | 20 | 22 | |||||
Property Plant And Equipment Net | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | |||||
Finite Lived Intangible Assets Net | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | |||||
Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | - | - | 5 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 28 | 29 | 28 | 27 | 26 | 27 | 27 | 27 | 27 | 28 | 28 | 35 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 3 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | |||||
Accrued Liabilities Current | 3 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 2 | 1 | 2 | 1 | |||||
Notes Payable Current | - | - | - | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | |||||
Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |||||
Employee Related Liabilities Current | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | |||||
Finance Lease Liability Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 7 | 9 | 8 | 8 | 6 | 8 | 7 | 6 | 5 | 5 | 4 | 4 | |||||
Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Liabilities | 10 | 12 | 11 | 11 | 9 | 11 | 10 | 10 | 9 | 8 | 8 | 8 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 57 | 55 | 52 | 51 | 51 | 50 | 50 | 49 | 48 | 48 | 47 | 47 | |||||
Treasury Stock Value | -6 | -6 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | |||||
Retained Earnings Accumulated Deficit | -33 | -33 | -32 | -32 | -31 | -31 | -29 | -28 | -26 | -25 | -23 | -16 | |||||
Stockholders Equity | 18 | 17 | 17 | 16 | 17 | 16 | 17 | 18 | 19 | 19 | 20 | 27 | |||||
Liabilities And Stockholders Equity | 28 | 29 | 28 | 27 | 26 | 27 | 27 | 27 | 27 | 28 | 28 | 35 | |||||
Allowance For Doubtful Accounts Receivable Current | - | - | - | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | 1 | 1 | 1 | 1 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Rent Receivables Net Noncurrent | - | - | - | - | - | - | - | - | 7 | 6 | 6 | - | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | |||||
Common Stock Shares Issued | 50 | 50 | 50 | 50 | 50 | 50 | 49 | 49 | 49 | 49 | 49 | 49 | |||||
Shares Outstanding | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | |||||
Treasury Stock Common Shares | - | - | - | - | - | - | - | - | - | - | - | 3 | |||||
Treasury Stock Preferred Shares | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.25% | 11.22% | -4.49% | - | - | - | - | - | - | - | - | - |
| 2025 | -0.74% | 33.46% | 27.21% | 29.45% | 21.47% | 30.06% | 47.35% | 48.41% | 42.59% | 0.23% | -5.57% | -5.80% |
| 2024 | -2.22% | 17.78% | 12.00% | 18.31% | 30.05% | 18.78% | 18.75% | 21.88% | 37.19% | -30.49% | -13.11% | -17.68% |
| 2023 | - | - | - | 10.55% | 13.92% | -2.53% | 4.57% | 12.10% | -3.65% | 17.45% | 9.43% | 0.47% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.72 | 2.33 | 2.44 | 2.48 | 2.91 | 2.44 | 2.66 | 2.99 | 3.77 | 4.01 | 4.55 | 5.14 | |||||
| Quick Ratio | 2.00 | 1.70 | 1.88 | 1.78 | 2.17 | 1.92 | 2.16 | 2.22 | 3.17 | 3.19 | 3.49 | 3.70 | |||||
| Working Capital | 12.33M | 11.74M | 11.79M | 11.59M | 11.53M | 11.20M | 11.93M | 12.60M | 14.23M | 14.63M | 15.80M | 17.46M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.55 | 0.69 | 0.65 | 0.65 | 0.54 | 0.67 | 0.62 | 0.54 | 0.46 | 0.44 | 0.40 | 0.29 | |||||
| Interest Coverage TTM | -5.86 | -8.61 | -10.13 | -7.19 | -8.13 | -11.07 | -14.50 | -62.43 | - | - | - | - | |||||
| Debt Ratio | 0.35 | 0.41 | 0.40 | 0.39 | 0.35 | 0.40 | 0.38 | 0.35 | 0.31 | 0.30 | 0.28 | 0.22 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.69 | 1.55 | 1.48 | 1.43 | 1.40 | 1.28 | 1.21 | 1.02 | 0.97 | 0.89 | 0.81 | 0.74 | |||||
| Days Sales Outstanding TTM | - | 50.34 | 52.94 | 49.40 | 53.37 | 53.80 | 52.97 | 52.57 | 56.18 | 53.26 | 48.66 | 58.05 | |||||
| Receivables Turnover TTM | - | 7.25 | 6.89 | 7.39 | 6.84 | 6.78 | 6.89 | 6.94 | 6.50 | 6.85 | 7.50 | 6.29 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.04 | -0.05 | -0.06 | -0.08 | -0.10 | -0.12 | -0.13 | -0.26 | -0.26 | -0.29 | -0.30 | -0.18 | |||||
| Free Cash Flow Per Share TTM | 0.01 | -0.01 | -0.03 | -0.01 | -0.06 | -0.04 | -0.04 | -0.04 | -0.02 | -0.03 | -0.12 | -0.12 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 62.43% | 61.93% | 62.26% | 62.32% | 63.15% | 63.49% | 63.40% | 62.82% | 62.49% | 60.24% | 58.59% | 57.38% | |||||
| Operating Profit Margin TTM | -3.66% | -5.99% | -7.23% | -10.28% | -13.16% | -16.33% | -19.16% | -22.05% | -23.18% | -31.29% | -36.01% | -36.91% | |||||
| Net Profit Margin TTM | -4.03% | -5.27% | -6.41% | -9.50% | -12.25% | -15.10% | -18.03% | -37.42% | -38.16% | -45.24% | -48.18% | -28.78% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 22.41% | 23.30% | 22.23% | 22.12% | 19.57% | 19.65% | 17.98% | 11.57% | 4.70% | 0.96% | 2.23% | 6.04% | |||||
| Net Income Growth (1Y) | -59.70% | -56.98% | -56.52% | -68.99% | -61.60% | -60.07% | -55.85% | 45.08% | 45.01% | 55.44% | 58.65% | 6.44% | |||||
| EPS Growth (1Y) | -59.61% | -57.33% | -56.88% | -71.40% | -61.92% | -60.31% | -56.04% | 44.41% | 44.36% | 54.68% | 56.57% | 5.03% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -106.38 | -87.90 | -101.73 | -51.29 | -36.63 | -22.05 | -29.07 | -10.46 | -10.32 | -8.13 | -8.15 | -14.93 | |||||
| P/B TTM | 10.72 | 11.84 | 15.74 | 11.56 | 10.01 | 7.15 | 10.49 | 7.06 | 6.49 | 5.64 | 5.50 | 4.49 | |||||
| P/S TTM | 4.29 | 4.63 | 6.52 | 4.87 | 4.49 | 3.33 | 5.24 | 3.91 | 3.94 | 3.68 | 3.93 | 4.30 | |||||
| Market Cap | 193.55M | 200.30M | 268.35M | 190.40M | 165.37M | 116.79M | 176.34M | 125.17M | 121.40M | 107.88M | 111.95M | 123.23M | |||||
| Enterprise Value | 185.26M | 191.70M | 259.68M | 182.51M | 157.58M | 108.49M | 167.35M | 117.11M | 111.31M | 97.62M | 101.21M | 113.34M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 379.38K | -649.96K | -1.30M | -646.85K | -2.67M | -1.91M | -1.70M | -1.70M | -1.08M | -1.22M | -5.68M | -5.46M | |||||
| Net Debt | -8.29M | -8.59M | -8.67M | -7.89M | -7.79M | -8.31M | -8.99M | -8.06M | -10.09M | -10.26M | -10.74M | -9.89M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
KORU Medical Systems, Inc. (KRMD) — SEC Financial Statements & Analysis
KORU Medical Systems, Inc. (KRMD) is a surgical & medical instruments & apparatus company, incorporated in DE. KORU Medical Systems, Inc. trades on Nasdaq as: KRMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), KORU Medical Systems, Inc. reported a 22.41% year-over-year revenue growth, a Gross Profit Margin of 62.43% (TTM), a Debt-to-Equity ratio of 0.55x, a Price-to-Sales (P/S) ratio of 4.29x (TTM), a Price-to-Book (P/B) ratio of 10.72x (TTM), at a market cap of $193.55M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 22.41%
- Gross Profit Margin TTM
- 62.43%
- Debt To Equity
- 0.55x
- P/S TTM
- 4.29x
- P/B TTM
- 10.72x
- Market Cap
- $193.55M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is KORU Medical Systems, Inc. in?
KORU Medical Systems, Inc. (KRMD) operates in the Surgical & Medical Instruments & Apparatus industry.
What is KRMD's market cap?
KORU Medical Systems, Inc. (KRMD) has a market capitalization of $193.55M as of 2026-06-30.
What exchange does KRMD trade on?
KORU Medical Systems, Inc. (KRMD) trades on the Nasdaq.
Where is KORU Medical Systems, Inc. incorporated?
KORU Medical Systems, Inc. is incorporated in DE.